Shares of Willow Biosciences Inc. (TSE:WLLW – Get Free Report) fell 12.5% on Thursday . The stock traded as low as C$0.04 and last traded at C$0.04. 164,688 shares traded hands during trading, a decline of 69% from the average session volume of 523,611 shares. The stock had previously closed at C$0.04.
Willow Biosciences Stock Performance
The firm has a 50-day moving average of C$0.05 and a two-hundred day moving average of C$0.08. The company has a quick ratio of 19.71, a current ratio of 0.80 and a debt-to-equity ratio of 902.05. The company has a market capitalization of C$5.79 million, a PE ratio of -0.73 and a beta of 1.13.
Willow Biosciences Company Profile
Willow Biosciences Inc is a Canadian biotechnology company based in Calgary. It produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Geographically, it derives a majority of revenue from Canada.
Read More
- Five stocks we like better than Willow Biosciences
- What is the FTSE 100 index?
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- DuPont’s Electronics Spinoff: The Start of Something Big
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for Willow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Willow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.